[期刊] Nature [日期] 2026-06-03 [PMID] 42236947 [IF] ~50 [类型] 原创研究

Spermine is an endogenous iron chelator that inhibits ferroptosis

Man Li, Xuexin Yu, Shuqin Ouyang, Xiaohong Chen, Huiqi Yu et al.

Nature | DOI: 10.1038/s41586-026-10597-2

[分数] Claude AI 五维评估

总分 (50)
44
逻辑完整性
9
方法学水平
9
创新性
10
可借鉴性
7
临床转化
9

[摘要] 核心发现

Spermine is an endogenous iron chelator that inhibits ferroptosis.
Ferroptosis is an iron-dependent form of cell death driven by lipid peroxidation.
Here we identify spermine—a polyamine derived from spermidine—as an endogenous iron chelator that directly suppresses ferroptosis.
Integrating metabolomics, stable isotope tracing and biophysical studies of the interaction between spermine and Fe²⁺ ions,
we demonstrate that aldehyde dehydrogenase 18 family member A1 (ALDH18A1) promotes an alternative glutamine-dependent pathway
for de novo spermine synthesis that is distinct from the classical polyamine biosynthesis route.
ALDH18A1-mediated spermine production protects cells from ferroptotic cell death by chelating intracellular ferrous iron,
thereby limiting Fenton chemistry and subsequent lipid peroxidation. Targeting ALDH18A1 with a specific small-molecule inhibitor
or genetic ablation sensitizes cancer cells to ferroptosis in vitro and in vivo, suppresses liver tumour growth,
and mitigates tissue ischaemia–reperfusion injury. These findings reveal a metabolic vulnerability whereby cells exploit
polyamine metabolism to control iron bioavailability and ferroptosis susceptibility.

[图文] 核心结果解读

Fig1
Figure 1 | Polyamine metabolism-mediated spermine production inhibits ferroptosis. Identification of polyamine metabolites as ferroptosis suppressors through metabolomics screening.
【铁死亡表型筛选】用户可参考本文的代谢组学筛选策略,在自己的体系中(过表达RhoA乳酸化突变体)系统筛查乳酸化如何改变细胞对铁死亡/其他死亡方式的敏感性。建议使用脂质过氧化探针C11-BODIPY 581/591和FerroOrange探针。
Fig2
Figure 2 | Spermine functions as a ferrous ion chelator. Biophysical and biochemical characterization of spermine-Fe²⁺ interaction, demonstrating direct iron chelation activity.
【金属螯合实验设计】本文对spermine-Fe²⁺相互作用的生物物理表征方法(ITC、EPR、穆斯堡尔谱)可直接被用户借鉴:若用户猜测乳酸化RhoA可能通过改变铁代谢影响mitoxyperiosis敏感性,可用类似策略验证。
Fig3
Figure 3 | ALDH18A1 overexpression drives glutaminolysis-linked polyamine biosynthesis. Discovery of an alternative glutamine-dependent pathway for de novo spermine synthesis via ALDH18A1.
【代谢通路发现策略】ALDH18A1的谷氨酰胺依赖通路发现策略非常值得学习。用户可在自己的Warburg/乳酸体系中,结合稳定同位素示踪(³C-葡萄糖→乳酸追踪)和代谢组学定位关键代谢节点。
Fig4
Figure 4 | Targeting ALDH18A1 prevents liver tumorigenesis by promoting ferroptosis. In vivo evidence that ALDH18A1 inhibition induces ferroptosis and suppresses tumour growth.
【体内Ferroptosis验证】本文的肝癌小鼠模型为体内验证铁死亡提供了完整范式。用户若希望在博一课题中增加体内数据(如xenograft模型),可参考本文的给药方案和铁死亡标志物检测(4-HNE、MDA、GPX4 IHC)。
Fig5
Figure 5 | Spermine mitigates tissue ischaemia-reperfusion injury by suppressing ferroptosis. Therapeutic potential of spermine in protecting against ischaemia-reperfusion injury through ferroptosis suppression.
【治疗转化策略】IRI模型的保护实验设计可直接迁移至用户的脑缺血研究方向。spermine作为内源性代谢物具有良好安全性,若用户的LDHA抑制策略发现类似保护效果,可参考本文的给药剂量和检测窗口。

[小结] 科研启示

本研究首次发现精胺(spermine)作为内源性铁螯合剂直接抑制铁死亡的机制。 核心发现为:ALDH18A1通过谷氨酰胺依赖的新途径合成精胺,精胺通过螯合Fe²⁺抑制Fenton反应和脂质过氧化,从而阻断铁死亡。

对用户课题的启示:
(1) 本文建立的内源性代谢物-铁螯合-铁死亡调控范式,与用户的Warburg效应-乳酸-细胞死亡课题高度互补。
(2) 代谢组学筛选策略可迁移至您的体系:若乳酸化RhoA通过改变代谢重编程影响死亡敏感性,可用类似方法筛查关键代谢节点。
(3) 本文的ALDH18A1小分子抑制剂策略值得借鉴:若您的PCAF-RhoA乳酸化轴验证成功,可开发靶向PCAF或LDHA的小分子以重启mitoxyperiosis。
(4) 铁死亡与mitoxyperiosis可能存在crosstalk:两者均涉及线粒体功能改变和膜损伤,值得探索乳酸化是否同时调控两种死亡通路的切换。